financetom
Business
financetom
/
Business
/
NextEra CEO says renewables needed as bridge to expanding gas power
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
NextEra CEO says renewables needed as bridge to expanding gas power
Jun 10, 2025 8:03 AM

WASHINGTON, June 10 (Reuters) - Renewable energy sources

like wind and solar power are needed to meet rapidly growing

energy demand in the United States amid near-term obstacles to

increasing natural gas capacity, said NextEra CEO John Ketchum

on Tuesday.

The head of the Florida-based power producer said at the

Politico Energy Summit that competition and high costs to obtain

gas turbines, a construction labor shortage, and the costs

associated with tariffs mean that it will take at least seven

years to get new gas-fired power plants online.

"We need a bridge to get ourselves to 2032 when that gas

shows up ... And when that gas shows up, it's going be three

times more expensive than it's ever been," Ketchum said.

"If we take renewables off the table, we are going to have a

real power shortage problem in this country."

U.S. House lawmakers narrowly passed a budget reconciliation

bill last month that would phase out clean energy tax credits,

slash spending on renewables, and claw back other

climate-related funds.

The House bill, which is now being debated by the Senate,

shortens the window for developers to start and complete new

clean energy projects to qualify for tax credits, and makes the

incentives unworkable, Ketchum said.

Ketchum's comments reverse an oft-repeated defense of

natural gas in the fossil fuel industry during previous

administrations seeking to fight climate change that had framed

the fuel as a bridge to a renewables-driven carbon-free energy

system.

Trump opposes renewable energy subsidies and wants to expand

production of oil, gas and coal. He has also declared an "energy

emergency" to spur more fuel and electricity production, in part

to meet growing demand for power for data centers and artificial

intelligence.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Tractor Supply Q4 Earnings Miss Estimates, Stock Falls: CEO Expects 'Macro Headwinds To Abate'
Tractor Supply Q4 Earnings Miss Estimates, Stock Falls: CEO Expects 'Macro Headwinds To Abate'
Jan 30, 2025
Tractor Supply Company ( TSCO ) shares are trading lower on Thursday. The company reported fourth-quarter earnings per share of 44 cents, missing the street view of 46 cents. Quarterly sales of $3.77 billion missed the analyst consensus estimate of $3.78 billion. Fourth-quarter net sales rose 3.1%, with a 0.6% increase in comparable store sales and a 2.3% growth in...
Schneider National Q4 Adjusted Earnings Rise, Operating Revenue Falls; 2025 Adjusted EPS Guidance Issued
Schneider National Q4 Adjusted Earnings Rise, Operating Revenue Falls; 2025 Adjusted EPS Guidance Issued
Jan 30, 2025
09:15 AM EST, 01/30/2025 (MT Newswires) -- Schneider National ( SNDR ) reported Q4 adjusted earnings Thursday of $0.20 per diluted share, up from $0.16 a year earlier. Analysts polled by FactSet expected $0.20. Operating revenue for the quarter ended Dec. 31 was $1.34 billion, down from $1.37 billion a year earlier. Analysts surveyed by FactSet expected $1.36 billion. For...
Tectonic Therapeutic Shares Soar Pre-Bell Following Interim Data From TX45 Trial
Tectonic Therapeutic Shares Soar Pre-Bell Following Interim Data From TX45 Trial
Jan 30, 2025
09:18 AM EST, 01/30/2025 (MT Newswires) -- Tectonic Therapeutic ( TECX ) shares climbed 90% in Thursday's premarket session after the company said a phase 1b trial showed that TX45 improved left ventricular function and pulmonary hemodynamics. The biotech firm said TX45 was well tolerated with no serious or severe adverse events, discontinuations, infusion reactions, or drug-related adverse events. These...
Levi Strauss Sees Gloomy FY25 Despite Solid Q4, Stock Slides
Levi Strauss Sees Gloomy FY25 Despite Solid Q4, Stock Slides
Jan 30, 2025
Shares of clothing major Levi Strauss & Co ( LEVI ) are trading lower in premarket on Thursday. Levi Strauss had provided a weaker outlook for FY25, expecting revenues to decline (1)% – (2)%. The company sees FY25 adjusted EPS of $1.20 – $1.25 against an estimate of $1.37. The Denim jeans maker reported a fourth-quarter FY24 sales growth of...
Copyright 2023-2025 - www.financetom.com All Rights Reserved